Silexion Therapeutics Corp (SLXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 157 | 350 | 433 | 223 | 195 |
| Operating Income | -157 | -350 | -433 | -223 | -195 |
| Other Income | 200 | 105 | 192 | -1 | 3 |
| Pre-tax Income | 43 | -246 | -242 | -224 | -192 |
| Net Income Continuous | 43 | -246 | -242 | -224 | -192 |
| Net Income | $43 | $-246 | $-242 | $-224 | $-192 |
| EPS Basic Total Ops | -1.35 | -2.70 | -2.70 | -2.70 | -1.35 |
| EPS Basic Continuous Ops | 1.72 | -9.88 | -9.94 | -9.01 | -7.71 |
| EPS Diluted Total Ops | -1.35 | -2.70 | -2.70 | -2.70 | -1.35 |
| EPS Diluted Continuous Ops | 1.72 | -9.88 | -9.94 | -9.01 | -7.71 |
| EBITDA(a) | $-157 | $-350 | $-433 | $-223 | $-195 |